Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:20 PM
Ignite Modification Date:
2025-12-24 @ 2:20 PM
NCT ID:
NCT01749995
Eligibility Criteria:
Inclusion Criteria:
* Patients should have reached the age of 70 or more at the moment of enrolment
* Patients should be eligible for standard CGA as per local practice (e.g. on the basis of positive screening with G8 or referred by a treating physician on the basis of clinical suspicion of vulnerability or frailty)
* Histologically confirmed diagnosis of cancer. All stages of cancer are eligible.
* Patients should be fluent in Dutch or French
* Patients must receive their primary oncology care (surgery, course of (neo)adjuvant or palliative chemotherapy, radiotherapy, targeted therapy, palliative care, experimental treatment as part of a clinical trial,...) planned in the General Hospital Groeninge
* Patients can be included before or at the start of a line of treatment but not during a line of treatment
* Patients should have signed informed consent
Exclusion Criteria:
* Patients who do not match the inclusion criteria
* Patients who are visiting the oncology clinic for a second opinion and do not wish to be treated in the General Hospital Groeninge
* Patients who already started a respective line of treatment
* Patients deemed fit on the basis of negative screening (negative result on G8) unless the treating physician suspects vulnerability or frailty based on clinical judgement
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
70 Years
Study:
NCT01749995
Study Brief:
Protocol Section:
NCT01749995